Search research articles
Contact Us
Filters
Showing results (201-210 of 320) with videos related to
Page
of 32
Sort By:
Pharmacogenetics and Genomics
|
February 16, 2007
ABCB1 and GST polymorphisms associated with TP53 status in breast cancer
Silje H Nordgard, Marylyn D Ritchie, Sigrid D Jensrud, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 11, 2006
Genetic variation in putative regulatory loci controlling gene expression in breast cancer
Vessela N Kristensen, Hege Edvardsen, Anya Tsalenko, et al.
Oncogene
|
August 18, 2009
Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines
S-K Leivonen, R Mäkelä, P Ostling, et al.
Scientific Reports
|
July 19, 2017
Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma
Sunniva Stordal Bjørklund, Anshuman Panda, Surendra Kumar, et al.
The American Journal of Pathology
|
January 12, 2008
Transcriptional networks inferred from molecular signatures of breast cancer
Ron Tongbai, Gila Idelman, Silje H Nordgard, et al.
Cancer Research
|
July 18, 2008
GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas
Jo Anders Rønneberg, Jörg Tost, Hiroko K Solvang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 15, 2010
Allele-specific copy number analysis of tumors
Peter Van Loo, Silje H Nordgard, Ole Christian Lingjærde, et al.
Genome Biology
|
August 23, 2014
Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis
Thomas Fleischer, Arnoldo Frigessi, Kevin C Johnson, et al.
Nature Communications
|
November 11, 2017
DNA methylation at enhancers identifies distinct breast cancer lineages
Thomas Fleischer, Xavier Tekpli, Anthony Mathelier, et al.
Cancer Research
|
February 5, 2015
Interaction between p53 mutation and a somatic HDMX biomarker better defines metastatic potential in breast cancer
Anna M Grawenda, Elen K Møller, Suzanne Lam, et al.
Page
of 32
Search research articles
Search
Showing results (201-210 of 320) with videos related to
Sort By:
Page
of 32
Pharmacogenetics and Genomics
|
February 16, 2007
ABCB1 and GST polymorphisms associated with TP53 status in breast cancer
Silje H Nordgard, Marylyn D Ritchie, Sigrid D Jensrud, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 11, 2006
Genetic variation in putative regulatory loci controlling gene expression in breast cancer
Vessela N Kristensen, Hege Edvardsen, Anya Tsalenko, et al.
Oncogene
|
August 18, 2009
Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines
S-K Leivonen, R Mäkelä, P Ostling, et al.
Scientific Reports
|
July 19, 2017
Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma
Sunniva Stordal Bjørklund, Anshuman Panda, Surendra Kumar, et al.
The American Journal of Pathology
|
January 12, 2008
Transcriptional networks inferred from molecular signatures of breast cancer
Ron Tongbai, Gila Idelman, Silje H Nordgard, et al.
Cancer Research
|
July 18, 2008
GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas
Jo Anders Rønneberg, Jörg Tost, Hiroko K Solvang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 15, 2010
Allele-specific copy number analysis of tumors
Peter Van Loo, Silje H Nordgard, Ole Christian Lingjærde, et al.
Genome Biology
|
August 23, 2014
Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis
Thomas Fleischer, Arnoldo Frigessi, Kevin C Johnson, et al.
Nature Communications
|
November 11, 2017
DNA methylation at enhancers identifies distinct breast cancer lineages
Thomas Fleischer, Xavier Tekpli, Anthony Mathelier, et al.
Cancer Research
|
February 5, 2015
Interaction between p53 mutation and a somatic HDMX biomarker better defines metastatic potential in breast cancer
Anna M Grawenda, Elen K Møller, Suzanne Lam, et al.
Page
of 32